New Treatment for Fatty Disease: FDA Rejects NASH Drug OCA Medicine & Technology Dec 14, 2023 Individuals with fatty liver hoping for a new treatment were left disappointed a few months ago when FDA rejected Intercept’s obeticholic acid (OCA). Continue reading to learn more.
TECH & INNOVATION OpenAI’s Whisper Faces Scrutiny Over Accuracy, Experts Find 'Hallucinated' Text in Transcripts